One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many drugs are designed to target tumor-specific antigens, which are molecules ...
A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified ...
In a recent article published in Nature Cancer, a multi-institutional research team led by The University of Osaka describes ...
Ava Salonia, who played with the Oceanside Sailors, died at age 16 following a nearly 12-month battle with acute myeloid ...
The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the ...
Scientists have identified a promising new drug target for acute myeloid leukemia, a deadly blood cancer with a five-year ...
A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified a promising new drug target for acute myeloid leukemia (AML), a deadly ...
The start of patient dosing represents a huge milestone for Moleculin and, importantly, the AML community. “Our team rem ...
Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that ...